Targeting B cell responses in universal influenza vaccine design
- 30 November 2011
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 32 (11) , 524-531
- https://doi.org/10.1016/j.it.2011.08.007
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infectionAntiviral Research, 2010
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences, 2010
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesProceedings of the National Academy of Sciences, 2010
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeProceedings of the National Academy of Sciences, 2010
- Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virusNature Communications, 2010
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Fusion mutants of the influenza virus hemagglutinin glycoproteinCell, 1985